We are live on ! Find out more
IA

IFP Advisors Portfolio holdings

AUM $5.54B
1-Year Est. Return 27.43%
This Fund
S&P 500
This Quarter Est. Return
+2.13%
1 Year Est. Return
+27.43%
3 Year Est. Return
+73.16%
5 Year Est. Return
+63.71%
10 Year Est. Return
–
AUM
$2.36B
AUM Growth
+$63M
Cap. Flow
+$27.6M
Cap. Flow %
1.17%
Top 10 Hldgs %
14.02%
Holding
4,444
New
256
Increased
1,587
Reduced
1,106
Closed
169

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$11.8M
2
JNJ icon
Johnson & Johnson
JNJ
+$5.67M
3
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$5.17M
4
IEMG icon
iShares Core MSCI Emerging Markets ETF
IEMG
+$4.9M
5
BND icon
Vanguard Total Bond Market
BND
+$4.33M

Top Sells

Rank Stock Value
1
VTI icon
Vanguard Total Stock Market ETF
VTI
+$45.1M
2
DBC icon
Invesco DB Commodity Index Tracking Fund
DBC
+$4.79M
3
MBB icon
iShares MBS ETF
MBB
+$4.33M
4
EMB icon
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
+$3.46M
5
XOP icon
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
+$3.41M

Sector Composition

Rank Sector Weight
1 Financials 6.78%
2 Technology 6.26%
3 Healthcare 6.25%
4 Consumer Staples 5.96%
5 Industrials 5.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NADL
4051
DELISTED
North Atlantic Drilling Ltd
NADL
$1K ﹤0.01%
550
– –
MRVC
4052
DELISTED
MRV Communications Inc
MRVC
$1K ﹤0.01%
142
– –
TIO
4053
DELISTED
Tingo Group, Inc. Common Stock
TIO
$1K ﹤0.01%
1,000
– –
SMI
4054
DELISTED
Semiconductor Manufacturing Intl
SMI
$1K ﹤0.01%
200
– –
ACLS icon
4055
Axcelis
ACLS
$4.12B
– –
-7
Closed –
ACRS icon
4056
Aclaris Therapeutics
ACRS
$730M
$0 ﹤0.01%
+12
New +$326
AEF
4057
abrdn Emerging Markets Equity Income Fund
AEF
$348M
– –
-350
Closed -$2K
AKBA icon
4058
Akebia Therapeutics
AKBA
$327M
$0 ﹤0.01%
28
– –
ALKS icon
4059
CALL
Alkermes
ALKS
$8.82B
– –
-600
Closed -$35K
ALNT icon
4060
Allient
ALNT
$1.47B
$0 ﹤0.01%
24
– –
ALTO icon
4061
Alto Ingredients
ALTO
$360M
$0 ﹤0.01%
1
– –
AMSC icon
4062
American Superconductor
AMSC
$1.48B
$0 ﹤0.01%
30
– –
BNBX
4063
DELISTED
BNB PLUS CORP
BNBX
– –
0
– –
APVO icon
4064
Aptevo Therapeutics
APVO
$5.47M
– –
0
– –
AQB icon
4065
AquaBounty Technologies
AQB
$4.68M
$0 ﹤0.01%
1
– –
ARCB icon
4066
ArcBest
ARCB
$3.44B
$0 ﹤0.01%
23
– –
ASA
4067
ASA Gold and Precious Metals
ASA
$948M
$0 ﹤0.01%
+100
New +$1.2K
ASG
4068
Liberty All-Star Growth Fund
ASG
$323M
$0 ﹤0.01%
15
-3,038
-100% -$14.3K
ASPS icon
4069
Altisource Portfolio Solutions
ASPS
$65.4M
$0 ﹤0.01%
2
– –
ASUR icon
4070
Asure Software
ASUR
$220M
$0 ﹤0.01%
28
– –
ATRA icon
4071
Atara Biotherapeutics
ATRA
$71.2M
– –
0
– –
AUPH icon
4072
Aurinia Pharmaceuticals
AUPH
$1.97B
– –
-1,000
Closed -$7K
AVNW icon
4073
Aviat Networks
AVNW
$262M
$0 ﹤0.01%
4
– –
BBU
4074
DELISTED
Brookfield Business Partners
BBU
$0 ﹤0.01%
9
– –
BLDP
4075
Ballard Power Systems
BLDP
$874M
$0 ﹤0.01%
58
-100
-63% -$281
161 162
163
164 165

Similar funds

AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
PWM
Perigon Wealth Management San Francisco, California $5.51B AUM 24.51% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
GVAG
Great Valley Advisor Group Wilmington, Delaware $5.5B AUM 20.56% 1-Year Est. Return
SWP
Sagespring Wealth Partners Franklin, Tennessee $5.49B AUM 19.47% 1-Year Est. Return

IFP Advisors's Q2 2017 Portfolio in Review

As of Q2 2017, IFP Advisors held 4,444 positions worth $2.36B, up 2.7% from $2.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

IFP Advisors's Q2 2017 filing shows 256 new, 1,587 increased, 1,106 reduced and 169 closed positions. Its largest new stake was Matinas BioPharma: 14,000 shares worth $1.18M. The largest sale was Vanguard Total Stock Market ETF, an estimated $45.1M.

By sector, the portfolio is most concentrated in Financials at 6.8% of assets, up from 6.5% a quarter earlier, followed by Technology and Healthcare.

  • IFP Advisors's largest Q2 2017 buy was Matinas BioPharma: 14,000 shares worth $1.18M.
  • IFP Advisors added most to iShares Core S&P 500 ETF in Q2 2017, an estimated $11.8M increase.
  • IFP Advisors's biggest Q2 2017 reduction was Invesco DB Commodity Index Tracking Fund, cutting an estimated $4.79M.
  • IFP Advisors fully exited Vanguard Total Stock Market ETF in Q2 2017, selling an estimated $45.1M.
  • IFP Advisors's ten largest holdings make up 14% of its $2.36B portfolio in Q2 2017.
  • IFP Advisors opened 256 new positions and closed 169 in Q2 2017.
  • IFP Advisors's portfolio value rose 2.7% quarter-over-quarter to $2.36B.

Based on IFP Advisors's 13F filing for Q2 2017, filed 31 Jul 2017.